Cargando…
Evaluation of Antihyperglycemic Effect of Extract of Moringa stenopetala (Baker f.) Aqueous Leaves on Alloxan-Induced Diabetic Rats
BACKGROUND: Diabetes is a serious metabolic disorder with complications that result in significant morbidity and mortality. Current drugs used for diabetes therapy are not free from side effects and do not restore normal glucose homeostasis. Therefore, the purpose of this study is to evaluate the an...
Autores principales: | , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7815076/ https://www.ncbi.nlm.nih.gov/pubmed/33488106 http://dx.doi.org/10.2147/DMSO.S266794 |
_version_ | 1783638162803785728 |
---|---|
author | Woldekidan, Samuel Mulu, Abay Ergetie, Wondwossen Teka, Frehiwot Meressa, Asfaw Tadele, Ashenif Abebe, Abiy Gemechu, Worku Gemeda, Negero Ashebir, Rekik Sileshi, Meron Tolcha, Yoseph |
author_facet | Woldekidan, Samuel Mulu, Abay Ergetie, Wondwossen Teka, Frehiwot Meressa, Asfaw Tadele, Ashenif Abebe, Abiy Gemechu, Worku Gemeda, Negero Ashebir, Rekik Sileshi, Meron Tolcha, Yoseph |
author_sort | Woldekidan, Samuel |
collection | PubMed |
description | BACKGROUND: Diabetes is a serious metabolic disorder with complications that result in significant morbidity and mortality. Current drugs used for diabetes therapy are not free from side effects and do not restore normal glucose homeostasis. Therefore, the purpose of this study is to evaluate the antidiabetic effect of Moringa stenopetala (Baker f.) aqueous leaves extract. METHODS: Thirty rats of weight 90–150 gram were distributed to five groups (n= 6). Then labelled as diabetic control (DC), normal control (NC), extract treated (MS 250 and 500mg/kg), and glibenclamide treated (GL 5mg/kg). The experimental rats were induced by intra-peritoneal injection of Alloxan monohydrate at a dose of 180 mg/kg after dissolving in normal saline. Clinical biochemistry such as AST, ALT, ALP, urea, creatinine, and cholesterol, blood glucose level, histopathological and preliminary phytochemical screening were evaluated. RESULTS: Phytochemical tests revealed the presence of different secondary metabolites. Alkaloid, flavonoid, tannin, saponin, phytosteroids, phenols and terpenoids. Moringa stenopetala (Baker f.) leaves aqueous extract (250 and 500mg/kg) improved the body weight of rats, showed remarkable reduction in blood glucose concentration (P<0.05), and significantly decreased serum urea, creatinine, ALT, AST and ALP (P < 0.05). Levels of serum cholesterol remained unaltered in the experimental groups when compared with diabetic control. Histopathology of non-treated rats showed deterioration of insulin producing pancreas cells; nevertheless, β-cells restoration was observed due to administration of Moringa stenopetala (Baker f.) aqueous leaves extract. CONCLUSION: It is possible to conclude that oral administration of Moringa stenopetala (Baker f.) aqueous leaf extracts (250mg/kg and 500mg/kg) for 28 days showed beneficial effects on antihyperglycemia, improved body weight and Alloxan damaged pancreatic β-cells, and restored biochemical changes. |
format | Online Article Text |
id | pubmed-7815076 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Dove |
record_format | MEDLINE/PubMed |
spelling | pubmed-78150762021-01-21 Evaluation of Antihyperglycemic Effect of Extract of Moringa stenopetala (Baker f.) Aqueous Leaves on Alloxan-Induced Diabetic Rats Woldekidan, Samuel Mulu, Abay Ergetie, Wondwossen Teka, Frehiwot Meressa, Asfaw Tadele, Ashenif Abebe, Abiy Gemechu, Worku Gemeda, Negero Ashebir, Rekik Sileshi, Meron Tolcha, Yoseph Diabetes Metab Syndr Obes Original Research BACKGROUND: Diabetes is a serious metabolic disorder with complications that result in significant morbidity and mortality. Current drugs used for diabetes therapy are not free from side effects and do not restore normal glucose homeostasis. Therefore, the purpose of this study is to evaluate the antidiabetic effect of Moringa stenopetala (Baker f.) aqueous leaves extract. METHODS: Thirty rats of weight 90–150 gram were distributed to five groups (n= 6). Then labelled as diabetic control (DC), normal control (NC), extract treated (MS 250 and 500mg/kg), and glibenclamide treated (GL 5mg/kg). The experimental rats were induced by intra-peritoneal injection of Alloxan monohydrate at a dose of 180 mg/kg after dissolving in normal saline. Clinical biochemistry such as AST, ALT, ALP, urea, creatinine, and cholesterol, blood glucose level, histopathological and preliminary phytochemical screening were evaluated. RESULTS: Phytochemical tests revealed the presence of different secondary metabolites. Alkaloid, flavonoid, tannin, saponin, phytosteroids, phenols and terpenoids. Moringa stenopetala (Baker f.) leaves aqueous extract (250 and 500mg/kg) improved the body weight of rats, showed remarkable reduction in blood glucose concentration (P<0.05), and significantly decreased serum urea, creatinine, ALT, AST and ALP (P < 0.05). Levels of serum cholesterol remained unaltered in the experimental groups when compared with diabetic control. Histopathology of non-treated rats showed deterioration of insulin producing pancreas cells; nevertheless, β-cells restoration was observed due to administration of Moringa stenopetala (Baker f.) aqueous leaves extract. CONCLUSION: It is possible to conclude that oral administration of Moringa stenopetala (Baker f.) aqueous leaf extracts (250mg/kg and 500mg/kg) for 28 days showed beneficial effects on antihyperglycemia, improved body weight and Alloxan damaged pancreatic β-cells, and restored biochemical changes. Dove 2021-01-15 /pmc/articles/PMC7815076/ /pubmed/33488106 http://dx.doi.org/10.2147/DMSO.S266794 Text en © 2021 Woldekidan et al. http://creativecommons.org/licenses/by-nc/3.0/ This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php). |
spellingShingle | Original Research Woldekidan, Samuel Mulu, Abay Ergetie, Wondwossen Teka, Frehiwot Meressa, Asfaw Tadele, Ashenif Abebe, Abiy Gemechu, Worku Gemeda, Negero Ashebir, Rekik Sileshi, Meron Tolcha, Yoseph Evaluation of Antihyperglycemic Effect of Extract of Moringa stenopetala (Baker f.) Aqueous Leaves on Alloxan-Induced Diabetic Rats |
title | Evaluation of Antihyperglycemic Effect of Extract of Moringa stenopetala (Baker f.) Aqueous Leaves on Alloxan-Induced Diabetic Rats |
title_full | Evaluation of Antihyperglycemic Effect of Extract of Moringa stenopetala (Baker f.) Aqueous Leaves on Alloxan-Induced Diabetic Rats |
title_fullStr | Evaluation of Antihyperglycemic Effect of Extract of Moringa stenopetala (Baker f.) Aqueous Leaves on Alloxan-Induced Diabetic Rats |
title_full_unstemmed | Evaluation of Antihyperglycemic Effect of Extract of Moringa stenopetala (Baker f.) Aqueous Leaves on Alloxan-Induced Diabetic Rats |
title_short | Evaluation of Antihyperglycemic Effect of Extract of Moringa stenopetala (Baker f.) Aqueous Leaves on Alloxan-Induced Diabetic Rats |
title_sort | evaluation of antihyperglycemic effect of extract of moringa stenopetala (baker f.) aqueous leaves on alloxan-induced diabetic rats |
topic | Original Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7815076/ https://www.ncbi.nlm.nih.gov/pubmed/33488106 http://dx.doi.org/10.2147/DMSO.S266794 |
work_keys_str_mv | AT woldekidansamuel evaluationofantihyperglycemiceffectofextractofmoringastenopetalabakerfaqueousleavesonalloxaninduceddiabeticrats AT muluabay evaluationofantihyperglycemiceffectofextractofmoringastenopetalabakerfaqueousleavesonalloxaninduceddiabeticrats AT ergetiewondwossen evaluationofantihyperglycemiceffectofextractofmoringastenopetalabakerfaqueousleavesonalloxaninduceddiabeticrats AT tekafrehiwot evaluationofantihyperglycemiceffectofextractofmoringastenopetalabakerfaqueousleavesonalloxaninduceddiabeticrats AT meressaasfaw evaluationofantihyperglycemiceffectofextractofmoringastenopetalabakerfaqueousleavesonalloxaninduceddiabeticrats AT tadeleashenif evaluationofantihyperglycemiceffectofextractofmoringastenopetalabakerfaqueousleavesonalloxaninduceddiabeticrats AT abebeabiy evaluationofantihyperglycemiceffectofextractofmoringastenopetalabakerfaqueousleavesonalloxaninduceddiabeticrats AT gemechuworku evaluationofantihyperglycemiceffectofextractofmoringastenopetalabakerfaqueousleavesonalloxaninduceddiabeticrats AT gemedanegero evaluationofantihyperglycemiceffectofextractofmoringastenopetalabakerfaqueousleavesonalloxaninduceddiabeticrats AT ashebirrekik evaluationofantihyperglycemiceffectofextractofmoringastenopetalabakerfaqueousleavesonalloxaninduceddiabeticrats AT sileshimeron evaluationofantihyperglycemiceffectofextractofmoringastenopetalabakerfaqueousleavesonalloxaninduceddiabeticrats AT tolchayoseph evaluationofantihyperglycemiceffectofextractofmoringastenopetalabakerfaqueousleavesonalloxaninduceddiabeticrats |